CH578016A5 - - Google Patents

Info

Publication number
CH578016A5
CH578016A5 CH941770A CH941770A CH578016A5 CH 578016 A5 CH578016 A5 CH 578016A5 CH 941770 A CH941770 A CH 941770A CH 941770 A CH941770 A CH 941770A CH 578016 A5 CH578016 A5 CH 578016A5
Authority
CH
Switzerland
Application number
CH941770A
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Publication of CH578016A5 publication Critical patent/CH578016A5/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CH941770A 1969-06-20 1970-06-22 CH578016A5 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3137169 1969-06-20

Publications (1)

Publication Number Publication Date
CH578016A5 true CH578016A5 (fr) 1976-07-30

Family

ID=10322106

Family Applications (1)

Application Number Title Priority Date Filing Date
CH941770A CH578016A5 (fr) 1969-06-20 1970-06-22

Country Status (19)

Country Link
US (2) US3714352A (fr)
JP (1) JPS5140135B1 (fr)
AT (2) AT326826B (fr)
BE (1) BE752165A (fr)
BR (1) BR6915173D0 (fr)
CA (1) CA1001073A (fr)
CH (1) CH578016A5 (fr)
DE (3) DE2030402B2 (fr)
DK (1) DK129390B (fr)
ES (1) ES380943A1 (fr)
FR (2) FR2052999B1 (fr)
GB (1) GB1317184A (fr)
IE (1) IE35203B1 (fr)
IL (1) IL34713A (fr)
NL (1) NL169480C (fr)
NO (1) NO133716C (fr)
PH (1) PH11156A (fr)
SE (2) SE406038B (fr)
ZA (1) ZA703861B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1376892A (en) * 1970-11-12 1974-12-11 Glaxo Lab Ltd 2beta-substituted-3alpha-hydroxysteroids and their esters
GB1377608A (en) * 1970-12-17 1974-12-18 Glaxo Lab Ltd 3alpha-hydroxy or acyloxy pregnene-21-ethers
US3917830A (en) * 1970-12-17 1975-11-04 Glaxo Lab Ltd Steroidal anaesthetic composition for intraveneous injection
US3900561A (en) * 1970-12-17 1975-08-19 Glaxo Lab Ltd Pharmaceutical compositions
GB1377609A (en) * 1970-12-17 1974-12-18 Glaxo Lab Ltd 3alpha-hydroxy-5alpha-pregnane compounds
GB1430932A (en) * 1972-05-05 1976-04-07 Glaxo Lab Ltd 21-fluoro-pregnanes
GB1436324A (en) * 1972-05-12 1976-05-19 Glaxo Lab Ltd Anaesthetic 3alpha-hydroxy pregnanes
IT1202370B (it) * 1976-07-12 1989-02-09 Hoffmann La Roche Soluzioni inietabili in cui l'atti vita' emolitica degli agenti di formazione di micelle naturali e' evitata mediante l'aggiunta di lipoidi e relativi prodotti
IT1204778B (it) 1986-02-04 1989-03-10 Mazzarella Basilio Formulazioni farmaceutiche iniettabili di principi attivi ad attivita' anestetica generale
IE920759A1 (en) * 1991-03-29 1992-10-07 Generali Costruzioni Srl Standardized step module for building prefabricated¹staircases, process for producing such module, prefabricated¹staircase and process for assembling prefabricated¹staircases
CZ300694A3 (en) * 1993-12-02 1996-05-15 Akzo Nobel Nv Substituted 2beta-morpholinandrostane derivatives, process of their preparation, their use for preparing pharmaceutical preparations and pharmaceutical compositions containing thereof
US6787530B1 (en) 1996-08-23 2004-09-07 Monash University Use of pregnane-diones as analgesic agents
CA2560298A1 (fr) * 2004-03-24 2005-09-29 Takeda Pharmaceutical Company Limited Preparation en teneur elevee
AU2019297195A1 (en) 2018-07-03 2021-01-14 Drawbridge Pharmaceuticals Pty Ltd Neuroactive steroids and methods of preparation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1281205A (fr) * 1956-12-21 1962-01-12 Organon Nv Procédé d'obtention de composés de la série du prégnane

Also Published As

Publication number Publication date
DK129390C (fr) 1975-02-24
CA1001073A (en) 1976-12-07
NL169480C (nl) 1982-07-16
DK129390B (da) 1974-10-07
FR2052999B1 (fr) 1974-06-14
SE406038B (sv) 1979-01-22
JPS5140135B1 (fr) 1976-11-01
SE401512B (sv) 1978-05-16
PH11156A (en) 1977-10-28
DE2030402A1 (de) 1971-01-21
NO133716B (fr) 1976-03-08
ZA703861B (en) 1971-02-24
DE2030402B2 (de) 1975-04-30
AT315375B (de) 1974-05-27
ATA710872A (de) 1975-03-15
IL34713A0 (en) 1970-08-19
ES380943A1 (es) 1973-07-01
NL169480B (nl) 1982-02-16
FR2052998B1 (fr) 1974-08-30
NL7009002A (fr) 1970-12-22
BR6915173D0 (pt) 1973-02-08
FR2052999A1 (fr) 1971-04-16
AT326826B (de) 1975-12-29
IE35203L (en) 1970-12-20
NO133716C (fr) 1976-06-16
DE2030402C3 (fr) 1975-12-11
GB1317184A (en) 1973-05-16
US3714352A (en) 1973-01-30
DE2065513A1 (de) 1974-04-04
US3781435A (en) 1973-12-25
IE35203B1 (en) 1975-12-10
FR2052998A1 (fr) 1971-04-16
IL34713A (en) 1975-06-25
DE2065332A1 (de) 1973-04-05
BE752165A (fr) 1970-12-18

Similar Documents

Publication Publication Date Title
AU465413B2 (fr)
FR2052998B1 (fr)
AU429630B2 (fr)
AU450150B2 (fr)
AU442375B2 (fr)
AU427401B2 (fr)
AU470301B1 (fr)
AU442357B2 (fr)
AU442535B2 (fr)
AU417208B2 (fr)
AU442463B2 (fr)
AU425297B2 (fr)
AU438128B2 (fr)
AU442380B2 (fr)
AU442322B2 (fr)
AU428074B2 (fr)
AU428129B2 (fr)
AU442538B2 (fr)
AU470661B1 (fr)
AU442554B2 (fr)
AU428131B2 (fr)
AU442285B2 (fr)
AU4540468A (fr)
CS148818B1 (fr)
CS148430B1 (fr)

Legal Events

Date Code Title Description
PL Patent ceased